Skip to main content
. Author manuscript; available in PMC: 2010 Feb 23.
Published in final edited form as: Int J Cancer. 2008 Sep 15;123(6):1376–1384. doi: 10.1002/ijc.23667

FIGURE 3.

FIGURE 3

PDEF expression is associated with longer survival of ovarian cancer patients. Kaplan–Meir analysis of survivability of ovarian cancer patients expressing PDEF in their tumour lesions (++: n = 7;+++: n = 6) vs. those without PDEF expression. Two-tailed Log-Rank test indicated that patient survivability is significantly different in comparison with PDEF negativity vs. PDEF positivity (p = 0.002). When fitting the data to the Cox model the relative risk estimate was 0.28 for the low PDEF groups (+) and 0.19 for the high PDEF groups (++/+++) in comparison with patients without PDEF expression in their tumour lesions (Wald Test [2] =9.6, p = 0.008).